Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial

Jeffrey A. How, Minghao Dang, Sanghoon Lee, Bryan Fellman, Shannon N. Westin, Anil K. Sood, Nicole D. Fleming, Aaron Shafer, Ying Yuan, Jinsong Liu, Li Zhao, Joseph Celestino, Richard Hajek, Margaret B. Morgan, Edwin R. Parra, Caddie D. Laberiano Fernandez, Claudio A. Arrechedera, Luisa Maren Solis Soto, Kathleen M. Schmeler, Alpa NickKaren H. Lu, Robert Coleman, Linghua Wang, Amir A. Jazaeri

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases